Herrscher Hugo, Artzner Thierry, Severac François, Faitot François, Kurtz Jean-Emmanuel, Janssen-Langenstein Ralph, Maestraggi Quentin, Schneider Francis, Michard Baptiste
Service de Réanimation Médicale, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
FMTS, Faculté de Médecine de Strasbourg, Université de Strasbourg, Strasbourg, France.
J Gastrointest Oncol. 2019 Apr;10(2):292-299. doi: 10.21037/jgo.2018.10.11.
Admission and management of patients with solid malignancies in intensive care unit (ICU) is a controversial topic. To this day, there is no data published concerning patients with gastric cancers hospitalized in ICU. This single center retrospective study reports the characteristics, outcome and prognostic factors of patients hospitalized in ICU for medical reasons over a period of 10 years.
We performed a single center retrospective study which reports the characteristics, outcome and prognostic factors of patients hospitalized in ICU for medical reasons over a period of 10 years.
Thirty-seven patients were included, among whom 24 (64.9%) had metastatic cancer. The most frequent diagnosis on admission was septic shock (48.6%) and 24 patients (64.9%) required intubation. Ten patients (27.0%) were alive 3 months after their admission in ICU. Metastatic cancer and intubation were independently associated with a higher risk of dying within 3 months of admission in multivariate analysis: odds ratio (OR) =13.7; 95% confidence interval (CI), 1.7-108 (P<0.01). Seventeen patients (45.9%) died during their ICU stay. Metastatic cancer: OR =89; 95% CI, 2.7-6,588, therapeutic intensification: OR =1,471; 95% CI, 9.8-811,973 and the logistic organ dysfunction score (LODS) on admission: OR =1.4; 95% CI, 1.1-2.3 were independently associated with mortality within the ICU in multivariate analysis (P<0.01).
This is the first study that examines the outcome and prognostic factors of patients with gastric cancers who require life-sustaining therapy in ICU. The identification of 3 months and ICU mortality prognostic factors could contribute to guiding clinicians in the management of these patients and assist health professionals in their discussions with these patients and their families.
重症监护病房(ICU)中实体恶性肿瘤患者的收治与管理是一个存在争议的话题。时至今日,尚无关于入住ICU的胃癌患者的数据发表。这项单中心回顾性研究报告了因医疗原因在ICU住院10年的患者的特征、结局及预后因素。
我们进行了一项单中心回顾性研究,报告了因医疗原因在ICU住院10年的患者的特征、结局及预后因素。
纳入了37例患者,其中24例(64.9%)患有转移性癌症。入院时最常见的诊断是感染性休克(48.6%),24例患者(64.9%)需要插管。10例患者(27.0%)在入住ICU 3个月后存活。在多变量分析中,转移性癌症和插管与入院后3个月内较高的死亡风险独立相关:比值比(OR)=13.7;95%置信区间(CI),1.7 - 108(P<0.01)。17例患者(45.9%)在ICU住院期间死亡。转移性癌症:OR =89;95% CI,2.7 - 6588,强化治疗:OR =1471;95% CI,9.8 - 811973以及入院时的逻辑器官功能障碍评分(LODS):OR =1.4;95% CI,1.1 - 2.3在多变量分析中与ICU内死亡率独立相关(P<0.01)。
这是第一项研究入住ICU需要生命维持治疗的胃癌患者的结局及预后因素的研究。确定3个月和ICU死亡率的预后因素有助于指导临床医生管理这些患者,并协助医疗专业人员与这些患者及其家属进行讨论。